Table 3.
Baseline characteristics of MDR-TB patients (N=751).
| Characteristics | Median (IQR) |
|---|---|
| Age | 44.00 (30.00–56.00) years |
| Length of MDR-TB treatment | 17.27 (8.50–24.37) months |
| Weight at start of therapy | 55.25 (50.00–62.00) kg |
| Characteristics | N (%) |
| Gender | |
| Male | 550 (73.2) |
| Female | 201 (26.8) |
| Race | |
| Chinese Han population | 743 (98.9) |
| Others | 8 (1.1) |
| MDR-TB category | |
| Pulmonary TB | 695 (92.5) |
| With extra pulmonary TB | 56 (7.5) |
| Previous TB treated history | |
| Yes | 651 (86.7) |
| No | 100 (13.3) |
| History of adverse events induced by TB treatment | |
| Yes | 133 (21.4) |
| No | 518 (79.6) |
| History of hepatitis | |
| Yes | 22 (2.9) |
| No | 729 (97.1) |
| Baseline comorbidity | |
| Yes | 276 (36.8) |
| Diabetes | 84 (30.3) |
| Chronic obstructive pulmonary disease | 54 (19.7) |
| Pulmonary heart disease | 42 (15.2) |
| Others | 96 (34.8) |
| No | 475 (63.2) |